Skip to content

taspoglutide

DRUG12 trials

Sponsors

Hoffmann-La Roche

Conditions

Diabetes Mellitus Type 2

Phase 1

Phase 2

Phase 3

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
CompletedNCT00717457
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2008-07-31End: 2011-03-31Updated: 2016-11-02
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
CompletedNCT00744367
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2008-10-31End: 2010-11-30Updated: 2016-08-05
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
CompletedNCT00744926
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2008-08-31End: 2010-04-30Updated: 2016-07-28
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
CompletedNCT00755287
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2008-11-30End: 2010-12-31Updated: 2016-07-29
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
CompletedNCT00754988
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2008-10-31End: 2011-03-31Updated: 2016-11-04
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
CompletedNCT00809705
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2008-12-31End: 2009-10-31Updated: 2016-11-02
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
CompletedNCT00823992
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2009-01-31End: 2010-05-31Updated: 2016-07-28
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
CompletedNCT00909597
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2009-05-31End: 2010-11-30Updated: 2016-11-02
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
CompletedNCT01018173
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2010-01-31End: 2011-01-31Updated: 2016-11-02
A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy
TerminatedNCT01051011
Hoffmann-La RocheDiabetes Mellitus Type 2
Start: 2010-01-31End: 2010-12-31Updated: 2016-11-02